Skip to main content
TipRanks
Go Ultimate75% OFF

MT Genex Corporation (9820) AI Stock Analysis

0 Followers
JP:9820

MT Genex Corporation

(TSE/TYO:9820)

Select Model
Rating:78Outperform
Price Target:JPY 4,953.00▲(15.19% Upside)
Action:reiterated
Date:11/14/26

The company's exceptionally strong, debt-light balance sheet and attractive low P/E valuation are the primary strengths. Robust revenue growth supports the positive outlook, though the recent sharp decline in operating cash flow is a key risk that prevents a higher score. Technical trends are bullish, with the price above all major moving averages.

Positive Factors
Strong Revenue GrowthAccelerating revenue growth indicates expanding business activity and supports the company’s ability to build scale. If maintained, stronger sales can provide a durable platform for reinvestment, operating leverage, and improved earnings capacity over the next several quarters.
Negative Factors
Weak Cash ConversionLow operating cash conversion means reported earnings are not consistently translating into cash from core operations. Working-capital drag or similar pressure could constrain self-funded growth and make liquidity generation more volatile over the next several quarters.

MT Genex Corporation (9820) vs. iShares MSCI Japan ETF (EWJ)

-5%0%5%10%15%20%25%30%35%JP:9820+27.33%EWJ+15.53%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 4.55B
Dividend Yield
0.93%
Average Volume (3M)
1,162
Price to Earnings (P/E)
7.3
Beta (1Y)
0.38
Revenue Growth
64.24%
EPS Growth
142.31%
Country
Japan
Employees
151
Sector
Industrials
Sector Strength
63
Industry
Engineering & Construction

MT Genex Corporation Business Overview & Revenue Model

Company Description

MT Genex Corporation, along with its group of companies, serves as a specialist contractor for both new construction and refurbishment of homes and commercial premises throughout Japan. Its activities are structured across four primary divisions: Ren...

MT Genex Corporation Financial Statement Overview

Summary

Strong revenue growth (+15.8%) and net income (+18.8%) are offset by a significant decline in operating cash flow to ¥79M. The balance sheet is exceptional with debt at only 1.9% of equity, providing a robust cushion. Overall financial health is good, but the cash flow dip warrants caution.

Income Statement

80Positive

Balance Sheet

95Very Positive

Cash Flow

60Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2026Mar 2025Mar 2024Mar 2023
Income Statement
Total Revenue4.17B3.95B4.71B3.79B3.26B2.97B
Gross Profit966.70M925.84M1.10B913.35M806.26M762.43M
EBITDA486.61M496.96M535.60M488.79M409.52M373.73M
Net Income259.32M264.99M314.86M277.57M241.66M212.62M
Balance Sheet
Total Assets5.12B5.12B5.65B5.01B4.76B4.59B
Cash, Cash Equivalents and Short-Term Investments2.19B2.01B1.99B1.84B1.83B1.85B
Total Debt93.49M102.33M84.66M171.23M181.80M251.47M
Total Liabilities925.45M995.44M1.25B1.10B1.09B1.11B
Stockholders Equity4.19B4.13B4.40B3.91B3.68B3.48B
Cash Flow
Free Cash Flow0277.26M54.99M257.94M76.61M388.92M
Operating Cash Flow0295.30M79.43M288.99M122.53M394.85M
Investing Cash Flow0-11.81M-31.95M-183.88M-22.49M-1.46M
Financing Cash Flow0-112.00M-60.88M-103.12M-112.62M-76.72M

MT Genex Corporation Technical Analysis

Technical Analysis SentimentPositive
Last Price4300.00

Price Trends

50DMA3780.50Positive
100DMA3728.40Positive
200DMA3656.50Positive

Market Momentum

MACD136.62Negative
RSI76.94Negative
STOCH89.89Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9820, the sentiment is Positive. The current price of 4300.00 is above the 20-day moving average (MA) of 3769.75, above the 50-day MA of 3780.50, and above the 200-day MA of 3656.50, indicating a bullish trend. The MACD of 136.62 indicates Negative momentum. The RSI at 76.94 is Negative, neither overbought nor oversold. The STOCH value of 89.89 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9820.

MT Genex Corporation Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

JP:9820 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:9820JP:982078OutperformJPY 4.63B7.26―0.93%64.24%142.31%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
JP:9087JP:908762NeutralJPY 4.13B22.13―1.67%6.19%-1.30%
JP:3948JP:394860NeutralJPY 6.72B19.81―4.28%0.32%67.81%
JP:7805JP:780554NeutralJPY 3.01B8.95―2.14%-1.49%-24.51%
JP:3958JP:395851NeutralJPY 3.12B16.34―3.70%-0.47%-33.66%
JP:7916JP:791649NeutralJPY 5.57B-24.14―2.75%-3.13%-142.20%

* Industrials Sector Average

Performance Comparison

-25%0%25%50%75%JP:9820JP:3948JP:3958JP:7805JP:7916JP:9087Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:9820 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:9820MT Genex Corporation4300.00918.1127.15%
JP:3948Hikari Business Form Co., Ltd.1168.00-43.38-3.58%
JP:3958Sasatoku Printing Co.,Ltd.541.004.960.92%
JP:7805PRINTNET INC.607.00-45.19-6.93%
JP:7916Mitsumura Printing Co., Ltd.1819.00195.3512.03%
JP:9087Takase Corporation2095.00848.5868.08%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 14, 2026